Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 2—February 2012

Diphtheria in the Postepidemic Period, Europe, 2000–2009

Karen S. WagnerComments to Author , Joanne M. White, Irina Lucenko, David Mercer, Natasha S. Crowcroft, Shona Neal, Androulla Efstratiou, on behalf of the Diphtheria Surveillance Network
Author affiliations: Health Protection Agency, London, UK (K.S. Wagner, J.M. White, N.S. Crowcroft, S. Neal, A. Efstratiou); State Agency Infectology Center of Latvia, Riga, Latvia (I. Lucenko); World Health Organization Regional Office for Europe, Copenhagen, Denmark (D. Mercer); Public Health Ontario, Toronto, Ontario, Canada (N.S. Crowcroft); University of Toronto Dalla Lana School of Public Health, Toronto (N.S. Crowcroft)

Main Article

Table 3

Vaccination status of case-patients and clinical manifestations of toxigenic Corynebacterium diphtheriae infections and epidemiologically linked cases without laboratory confirmation, Latvia, Europe, 2000–2009*

Vaccination status Classic diphtheria (with membrane) Mild diphtheria/ severe pharyngitis Cutaneous Asymptomatic Not known Total
Full 64† 118 0 71 0 253
Partial 1 3 0 5 0 9
Unvaccinated 74 70 1 18 0 163
Not known 2 8 0 63 210 283
Total 141 199 1 157 210 708

*p<0.001 by test for trend (vaccination status and disease severity).
†Includes 52 fully vaccinated case-patients with classic respiratory diphtheria (with membrane) from an outbreak in the military in 2000. The outbreak comprised 145 symptomatic case-patients and 25 asymptomatic contacts. A total of 96% of these case-patients and contacts were 18–23 years of age at the time of diagnosis. Spread of disease was traced to use of a communal drinking cup (13).

Main Article

  1. Begg  N. Diphtheria: manual for the management and control of diphtheria in the European region. Copenhagen: Expanded Programme on Immunization in the European Region of WHO; 1994.
  2. Vitek  CR, Wharton  M. Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis. 1998;4:53950. DOIPubMedGoogle Scholar
  3. Galazka  A. The changing epidemiology of diphtheria in the vaccine era. J Infect Dis. 2000;181(Suppl 1):S29. DOIPubMedGoogle Scholar
  4. Wagner  KS, White  JM, Crowcroft  NS, De Martin  S, Mann  G, Efstratiou  A. Diphtheria in the United Kingdom, 1986–2008: the increasing role of Corynebacterium ulcerans. Epidemiol Infect. 2010;138:151930. DOIPubMedGoogle Scholar
  5. Bonmarin  I, Guiso  N, Le Flèche-Matéos  A, Patey  O, Grimont  PAD, Levy-Bruhl  D. Diphtheria: a zoonotic disease in France? Vaccine. 2009;27:4196200. DOIPubMedGoogle Scholar
  6. Tiwari  TS, Golaz  A, Yu  DT, Ehresmann  KR, Jones  TF, Hill  HE, Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis. 2008;46:395401. DOIPubMedGoogle Scholar
  7. Dorella  FA, Pacheco  LG, Oliveira  SC, Miyoshi  A, Azevedo  V. Corynebacterium pseudotuberculosis: microbiology, biochemical properties, pathogenesis and molecular studies of virulence. Vet Res. 2006;37:20118. DOIPubMedGoogle Scholar
  8. Vitek  CR, Wharton  M. Diphtheria toxoid. In: Plotkin S, Orenstein W, Offic P, editors. Vaccines. Amsterdam: Elsevier Inc.; 2008. p. 139–56.
  9. Efstratiou  A, Maple  PA. Manual for the laboratory diagnosis of diphtheria. Copenhagen: Expanded Programme on Immunization in the European Region of WHO; 1994.
  10. Wagner  KS, White  JM, Neal  S, Crowcroft  NS, Kuprevičiene  N, Paberza  R, Screening for Corynebacterium diphtheriae and Corynebacterium ulcerans in patients with upper respiratory tract infections 2007–2008: a multi-centre European study. Clin Microbiol Infect. 2011;17:51925. DOIPubMedGoogle Scholar
  11. Population Division of Economic and Social Affairs of the United Nations Secretariat. World populations prospects: the 2010 revision [cited 2011 Sep 30].
  12. Cuzick  J. A Wilcoxon-type test for trend. Stat Med. 1985;4:8790. DOIPubMedGoogle Scholar
  13. Ohuabunwo  C, Perevoscikovs  J, Griskevica  A, Gargiullo  P, Brilla  A, Viksna  L, Respiratory diphtheria among highly vaccinated military trainees in Latvia: improved protection from DT compared with Td booster vaccination. Scand J Infect Dis. 2005;37:81320. DOIPubMedGoogle Scholar
  14. Hogg  RA, Wessels  J, Hart  J, Efstratiou  A, De Zoysa  A, Mann  G, Possible zoonotic transmission of toxigenic Corynebacterium ulcerans from companion animals in a human case of fatal diphtheria. Vet Rec. 2009;165:6912.PubMedGoogle Scholar
  15. Lartigue  MF, Monnet  X, Le Fleche  A, Grimont  PA, Benet  JJ, Durrbach  A, Corynebacterium ulcerans in an immunocompromised patient with diphtheria and her dog. J Clin Microbiol. 2005;43:9991001. DOIPubMedGoogle Scholar
  16. Schuhegger  R, Schoerner  C, Dlugaiczyk  J, Lichtenfeld  I, Trouillier  A, Zeller-Peronnet  V, Pigs as source for toxigenic Corynebacterium ulcerans. Emerg Infect Dis. 2009;15:13145. DOIPubMedGoogle Scholar
  17. Lumio  J, Suomalainen  P, Olander  RM, Saxen  H, Salo  E. Fatal case of diphtheria in an unvaccinated infant in Finland. Pediatr Infect Dis J. 2003;22:8446. DOIPubMedGoogle Scholar
  18. Health Protection Agency. Death in a child infected with toxigenic Corynebacterium diphtheriae in London. Health Protection Report 2008;2(19) [cited 2011 Nov 14].
  19. Dittmann  S, Wharton  M, Vitek  C, Ciotti  M, Galazka  A, Guichard  S, Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis. 2000;181(Suppl 1):S1022. DOIPubMedGoogle Scholar
  20. Crowcroft  NS, White  JM, Efstratiou  A, George  R. Screening and toxigenic corynebacteria spread. Emerg Infect Dis. 2006;12:5201.PubMedGoogle Scholar
  21. Neal  SE, Efstratiou  A. International external quality assurance for the laboratory diagnosis of diphtheria. J Clin Microbiol. 2009;47:403742. DOIPubMedGoogle Scholar
  22. Wagner  KS, Stickings  P, White  JM, Neal  S, Crowcroft  NS, Sesardic  D, A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use. Vaccine. 2009;28:1420. DOIPubMedGoogle Scholar
  23. Seto  Y, Komiya  T, Iwaki  M, Kohda  T, Mukamoto  M, Takahashi  M, Properties of corynephage attachment site and molecular epidemiology of Corynebacterium ulcerans isolated from humans and animals in Japan. Jpn J Infect Dis. 2008;61:11622.PubMedGoogle Scholar
  24. De Zoysa  A, Hawkey  PM, Engler  K, George  R, Mann  G, Reilly  W, Characterization of toxigenic Corynebacterium ulcerans strains isolated from humans and domestic cats in the United Kingdom. J Clin Microbiol. 2005;43:437781. DOIPubMedGoogle Scholar
  25. Vaccine European New Integrated Collaboration Effort (VENICE). Report on the vaccination coverage assessment in Europe. 2007 [cited 2011 Nov 14].
  26. World Health Organization. WHO/UNICEF coverage estimates for 1980–2009, as of July 2010 [cited 2010 Sep 21].
  27. Larson  HJ, Cooper  LZ, Eskola  J, Katz  SL, Ratzan  S. Addressing the vaccine confidence gap. Lancet. 2011;378:52635. DOIPubMedGoogle Scholar
  28. Edmunds  WJ, Pebody  RG, Aggerback  H, Baron  S, Berbers  G, Conyn-van Spaendonck  MA, The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect. 2000;125:11325. DOIPubMedGoogle Scholar

Main Article

1Additional members of the Diphtheria Surveillance Network who contributed data are listed in Technical Appendix 1.

Page created: January 17, 2012
Page updated: January 17, 2012
Page reviewed: January 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.